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The new Framework for Practice highlights the limited evidence for our current clinical 
practice (1). It is helpful in emphasising the importance of accurate measurement of glucose 
concentrations, listening to the concerns of parents and acknowledging that untreated 
hypoglycaemia can have devastating longterm consequences.  However we have the 
following concerns: 
   
Screening thresholds 
The Framework recommends lowering a commonly accepted screening threshold in infants 
considered to be at risk of hypoglycaemia to a level that at any other time of life would be 
considered harmful.  It fails to acknowledge the differences between screening and 
diagnostic thresholds; something neonatologists are very familiar with in the management 
of babies with jaundice. Phototherapy is provided to many babies with bilirubin levels well 
below a harmful level to prevent a harmful level being reached. Screening interventions are 
intended to prevent harmful events.  Such thresholds will inevitably mean many individuals 
are treated ‘unnecessarily’ to avoid the risk of significant harm.  In 2000 Cornblath et al 
published guidance on ‘operational thresholds’ in keeping with the current BAPM 
framework (2). However, and possibly reflecting concerns about the lack of evidence for the 
safety of this lower operational threshold, in 2017 in the UK, >80% of neonatal units still 
used <2.6mmol/ as their defined hypoglycaemic threshold (3). A threshold of <2.6mmol/l 
provides an opportunity for intervention before damaging neuroglycopaenia occurs. 
 
Alternative Fuels and Hyperinsulinism 
 
What is an appropriate intervention depends on the whole clinical scenario, including the 
potential availability of alternative fuels. However, these are difficult to measure accurately 
at the cot side, and the clinical significance of particular levels in an individual in terms of 
physiology or pathology is still not entirely clear (4). Nevertheless, it is presumed that a 
hormonal milieu such as hyperinsulinism, that suppresses production of alternative fuels, is 
likely to increase risk of neurological damage.  
 
In this respect we have concerns that the Framework provides incongruent advice in 
recommending an intervention threshold of <2.0mmol/L for infants of diabetic mothers and 
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growth restricted infants, but advises that blood glucose concentrations should be kept  
>3.0mmol/l  in infants with suspected hyperinsulinism. Infants of diabetic mothers and 
growth restricted infants may also have transient hyperinsulinism (the diagnosis of which 
can be challenging and protracted in the newborn but is supported by raised cord c-peptide 
levels).   Those with clinical experience of managing children with congenital 
hyperinsulinism, and the family support groups, are concerned that the new Framework is 
likely to result in delayed diagnosis and under-treatment of such infants, with potentially 
devastating consequences for the individual baby and family (5).  
 
 
Evidence for harm 
  
Most outcome studies are limited by the infrequent measurement of glucose 
concentrations after birth, as well as lack of specific tools used for neurological assessment. 
The latest follow up data from the CHYLD cohort, most of whom had continuous glucose 
monitoring in the first week after birth, showed that neonatal glucose concentrations 
<2.6mmol/L were associated with substantially increased risk of impaired executive function 
and visual motor difficulty at 4.5 years, with greater risk in those with more severe 
(<2.0mmol/L), recurrent or clinically silent episodes. (6) By the age of 4.5 years, children 
have increased capacity for complex problem solving and attention control; impairments 
that cannot be detected early in life.  Previous studies have tended to focus on early and 
less specific deficits, and may not have been able to detect these specific problems. 
  
All data in this field are currently limited by their observational nature, but executive 
function and visual motor skills, although not primary outcomes, were prospectively 
hypothesised to be affected by hypoglycaemia in the CHYLD Study. Furthermore, the 
apparent dose-response relationship between the severity and frequency of hypoglycaemic 
episodes and the risk of low executive and visual motor function increases the likelihood 
that this is a true association. The fact that the clinical teams were blinded to the 
continuously collected glucose data, and clinical decisions were made independently of 
these data, should also have reduced bias.     
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Nevertheless, this study  was not restricted to babies born at term, and it is not possible in 
an observational study to exclude the possibility that unidentified antenatal factors may 
have contributed both to the hypoglycaemia and to the adverse outcomes.  Despite this, the 
underlying mechanism for neurological injury may still be hypoglycaemia.   
 
Finally, reducing screening thresholds, in the absence of sufficient reassuring outcome data, 
may result in discharge of babies who have not yet completed a successful metabolic 
transition after birth. This may result in more acute readmissions, as well as later 
neurodevelopmental impairment and so potentially more medico-legal claims for 
hypoglycaemic brain injury.  This new framework will inevitably achieve its objective of 
reducing admissions of term babies, and will keep many mothers and babies together, but 
will there be a cost? (7)   
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